Related Experiment Video

Updated: Aug 13, 2026

Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

Parkinsonism associated with basal ganglia cryptococcal abscesses in an immunocompetent patient

Sarah T Camargos1, Antonio L Teixeira, Francisco Cardoso

  • 1Movement Disorders Clinic, Neurology Service, Hospital das Clínicas, Belo Horizonte, and Department of Internal Medicine, Faculty of Medicine, Federal University of Minas Gerais, Brazil.

Movement Disorders : Official Journal of the Movement Disorder Society
|January 27, 2006
PubMed

Insights

Infectious agents rarely cause parkinsonism. This study details a case of persistent parkinsonism in an immunocompetent individual linked to cryptococcal abscesses in the basal ganglia.

Area of Science:

  • Neurology
  • Infectious Diseases

Background:

  • Parkinsonism is typically idiopathic or associated with neurodegenerative processes.
  • Infectious causes of parkinsonism are exceptionally rare in immunocompetent individuals.

Observation:

  • A case report of an immunocompetent patient presenting with persistent parkinsonism.

Findings:

  • The patient's parkinsonism was directly associated with the presence of cryptococcal abscesses within the basal ganglia.
  • This finding highlights a novel infectious etiology for parkinsonism.

Implications:

  • This case expands the differential diagnosis for parkinsonism to include fungal infections like cryptococcosis.
  • Further research may elucidate the mechanisms by which fungal infections impact the basal ganglia and induce parkinsonian symptoms.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...